Urinary and serum soluble CD25 complements urinary soluble CD163 to detect active renal anti-neutrophil cytoplasmic autoantibody-associated vasculitis: a cohort study (original ) (raw )Urinary CD4+ effector memory T cells reflect renal disease activity in antineutrophil cytoplasmic antibody-associated vasculitis
Wayel Abdulahad
Arthritis and Rheumatism, 2009
View PDFchevron_right
Urinary Soluble CD163 in Active Renal Vasculitis
Fionnuala Hickey
Journal of the American Society of Nephrology : JASN, 2016
View PDFchevron_right
Are urinary levels of high mobility group box 1 markers of active nephritis in anti-neutrophil cytoplasmic antibody-associated vasculitis?
Cees Kallenberg
Clinical & Experimental Immunology, 2014
View PDFchevron_right
Urinary Biomarkers in Relapsing Antineutrophil Cytoplasmic Antibody-associated Vasculitis
David Cuthbertson
The Journal of Rheumatology, 2013
View PDFchevron_right
Urine soluble CD163 (sCD163) as biomarker in glomerulonephritis: stability, reference interval and diagnostic performance
Okvendri Abrihari
Clinical Chemistry and Laboratory Medicine (CCLM), 2020
View PDFchevron_right
Identification and Validation of Urinary Biomarkers for Differential Diagnosis and Evaluation of Therapeutic Intervention in Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
Eshetu Atenafu
Molecular & Cellular Proteomics, 2009
View PDFchevron_right
Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort
Jacqueline Rivet
Nephrology Dialysis Transplantation, 2017
View PDFchevron_right
Review article: The role of CD4 + T cells in ANCA-associated systemic vasculitis
Wayel Abdulahad
Nephrology, 2009
View PDFchevron_right
Renal involvement at baseline can predict major renal relapse in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis
Mariagrazia Lorenzin
Clinical and Experimental Rheumatology, 2020
View PDFchevron_right
Circulating cytokine profile in anti-neutrophilic cytoplasmatic autoantibody-associated vasculitis: prediction of outcome?
Sophie Ohlsson
Mediators of Inflammation, 2004
View PDFchevron_right
#4790 Serum Biomarkers as Predictors of Renal Damage in Anca-Associated Vasculitides
Ricardo Verde
Nephrology Dialysis Transplantation
View PDFchevron_right
Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis
Veronica Tello Aguirre
Autoimmunity Reviews, 2013
View PDFchevron_right
Evolving Challenges in Diagnosis of Renal Vasculitis
than min aung
Journal of Medical Cases, 2021
View PDFchevron_right
Urinary soluble CD163: a non-invasive biomarker to monitor lupus nephritis
eya toumi
View PDFchevron_right
Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis
Cees Kallenberg
Nephrology Dialysis Transplantation, 2004
View PDFchevron_right
Tubulointerstitial damage and interstitial immune cell phenotypes are useful predictors for renal survival and relapse in antineutrophil cytoplasmic antibody-associated vasculitis
Raymond Azar
Journal of Nephrology, 2020
View PDFchevron_right
Incidence, prevalence, mortality and chronic renal damage of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a 20-year population-based cohort
Aishwarya Ravindran
Nephrology Dialysis Transplantation, 2018
View PDFchevron_right
Dendritic cells in renal biopsies of patients with ANCA-associated vasculitis
Jan Willem Cohen Tervaert
Nephrology Dialysis Transplantation, 2009
View PDFchevron_right
The cellular signature of urinary immune cells in Lupus nephritis: new insights into potential biomarkers
Robert Biesen
Arthritis research & therapy, 2015
View PDFchevron_right
Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis
Sophia Wells
Journal for ImmunoTherapy of Cancer, 2023
View PDFchevron_right
Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis
Renate Kain
Nephrology Dialysis Transplantation, 2005
View PDFchevron_right
Urinary CD8+ T-cell counts discriminate between active and inactive lupus nephritis
Wayel Abdulahad
Arthritis Research & Therapy, 2013
View PDFchevron_right
Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function
Patrick Nachman
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2015
View PDFchevron_right
Seasonal Influence on the Risk of Relapse at a Rise of Antineutrophil Cytoplasmic Antibodies in Vasculitis Patients with Renal Involvement
Jan Willem Cohen Tervaert
The Journal of rheumatology, 2017
View PDFchevron_right
#6260 Predicting Kidney Function and End-Stage Kidney Disease in Anca-Associated Vasculitis Using Anca, C-Reactive Protein and C3
Ricardo Verde
Nephrology Dialysis Transplantation
View PDFchevron_right
Antineutrophil Cytoplasmic Antibody- Associated Renal Vasculitis Treated With Autologous Mesenchymal Stromal Cells: Evaluation of the Contribution of Immune-Mediated Mechanisms
Valeria Corradetti , Libetta Carmelo
View PDFchevron_right
Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: clinico-pathological characterization and outcome
Lucio Manenti
Clinical Kidney Journal
View PDFchevron_right
Autoantibodies against glomerular endothelial cells in anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis
Johanna Westra
Nephrology, 2009
View PDFchevron_right
Urine IgM excretion predicts outcome in ANCA-associated renal vasculitis
omran bakoush
Nephrology Dialysis Transplantation, 2006
View PDFchevron_right
Circulating B Cells, Plasma Cells, and Treg Associate with ANCA Levels in ANCA-associated Vasculitis
loreto fernandez
Kidney International Reports
View PDFchevron_right
EVALUATION OF URINARY CD4 T-CELL LEVELS AS A BIO-MARKER FOR LUPUS NEPHRITIS AND ITS CORRELATION WITH DISEASE ACTIVITY
IJAR Indexing
View PDFchevron_right